🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.
Salud Compra fuertePrecio actual
61,65 USD
Máx. histórico
2.925,00
12011 días
Split 1:10 del 17/11/2011
Caída desde máximo
-97,89%
Rango 52 semanas
37,06 – 95,49
Variación hoy
+3,56%
Cierre anterior
59,53
Rango de hoy
59,06 – 61,99
Volumen hoy
1.487.357
Peor caída histórica
-99,96%
16/12/1993 → 16/12/2016
Aún sin recuperar
Volatilidad anualizada ⓘ
231,86%
- Nombre completo
- Arrowhead Pharmaceuticals, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 711
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 107,71 USD (puede no estar actualizado)
- Primera cotización
- 16/12/1993
- Precio actualizado
- hace 17 horas
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.
| Fecha | Ratio |
|---|---|
| 17/11/2011 | 1:10 |
| 15/01/2004 | 1:65 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/09/2011 | 4,90 | 5,00 | 4,83 | 4,90 | -0,20% | 3,47% | 4.310 |
| 08/09/2011 | 5,10 | 5,30 | 4,90 | 4,91 | -7,36% | 7,84% | 4.530 |
| 07/09/2011 | 4,90 | 5,50 | 4,90 | 5,30 | +8,16% | 12,24% | 4.600 |
| 06/09/2011 | 5,00 | 5,20 | 4,83 | 4,90 | -4,11% | 7,40% | 14.100 |
| 02/09/2011 | 5,48 | 5,59 | 5,00 | 5,11 | -8,75% | 10,77% | 5.320 |
| 01/09/2011 | 5,48 | 5,70 | 5,48 | 5,60 | +1,82% | 4,01% | 2.560 |
| 31/08/2011 | 5,50 | 5,50 | 5,48 | 5,50 | +0,18% | 0,36% | 3.060 |
| 30/08/2011 | 5,50 | 5,52 | 5,40 | 5,49 | +3,39% | 2,18% | 20.200 |
| 29/08/2011 | 5,40 | 5,45 | 5,20 | 5,31 | +8,37% | 4,63% | 11.020 |
| 26/08/2011 | 5,20 | 5,20 | 4,60 | 4,90 | +0,41% | 11,54% | 12.320 |
| 25/08/2011 | 4,50 | 4,89 | 4,50 | 4,88 | +13,23% | 8,67% | 5.690 |
| 24/08/2011 | 4,37 | 4,50 | 4,30 | 4,31 | -2,05% | 4,58% | 5.700 |
| 23/08/2011 | 4,50 | 4,90 | 4,26 | 4,40 | -2,65% | 14,22% | 6.890 |
| 22/08/2011 | 4,32 | 4,61 | 4,32 | 4,52 | +1,57% | 6,71% | 7.590 |
| 19/08/2011 | 4,55 | 4,55 | 4,21 | 4,45 | -1,11% | 7,47% | 8.300 |
| 18/08/2011 | 4,80 | 4,89 | 4,50 | 4,50 | -2,17% | 8,12% | 2.890 |
| 17/08/2011 | 4,70 | 5,00 | 4,60 | 4,60 | +0,00% | 8,51% | 5.210 |
| 16/08/2011 | 4,80 | 4,90 | 4,60 | 4,60 | -4,17% | 6,25% | 2.520 |
| 15/08/2011 | 4,90 | 5,00 | 4,43 | 4,80 | +4,35% | 11,63% | 4.140 |
| 12/08/2011 | 5,00 | 5,08 | 4,60 | 4,60 | -0,86% | 9,60% | 3.800 |
| 11/08/2011 | 4,50 | 4,80 | 4,40 | 4,64 | +5,45% | 8,89% | 3.650 |
| 10/08/2011 | 4,44 | 4,50 | 4,32 | 4,40 | -1,57% | 4,05% | 11.950 |
| 09/08/2011 | 4,90 | 4,90 | 4,20 | 4,47 | -8,78% | 14,29% | 44.990 |
| 08/08/2011 | 5,00 | 5,00 | 4,84 | 4,90 | -3,92% | 3,20% | 15.770 |
| 05/08/2011 | 5,50 | 5,50 | 5,00 | 5,10 | -3,77% | 9,09% | 19.250 |
| 04/08/2011 | 5,18 | 5,50 | 5,10 | 5,30 | +0,00% | 7,72% | 22.090 |
| 03/08/2011 | 5,50 | 5,69 | 5,11 | 5,30 | +0,00% | 10,55% | 4.890 |
| 02/08/2011 | 6,25 | 6,25 | 5,22 | 5,30 | -7,02% | 16,48% | 22.900 |
| 01/08/2011 | 5,30 | 5,80 | 5,30 | 5,70 | +7,55% | 9,43% | 12.630 |
| 29/07/2011 | 5,10 | 5,30 | 5,10 | 5,30 | +1,92% | 3,92% | 4.800 |